World's first trial aims to find best surgery for deadly aortic tear
NCT ID NCT06676371
Summary
This study is the world's first multi-center trial to compare two major surgeries for a life-threatening tear in the body's main artery (acute Type A aortic dissection). It will enroll 150 patients to see if a newer, more complex procedure (TARFET) leads to better 30-day survival than the current standard surgery (HAR). The goal is to find the safest and most effective approach for this critical emergency condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC DISSECTION TYPE A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prince of Wales Hospital
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Siriraj Hospital - Mahidol University
Bangkok, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital Vienna
Vienna, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.